Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Vertex Pharmaceuticals
Pharmaceutical Preparation ManufacturingUnited StatesNASDAQ: VRTX
Last verified 5 months agovrtx.com
Vertex Pharmaceuticals (often referred to simply as Vertex) is a global biotechnology company headquartered in the US, with significant operations worldwide. Established in 1989, Vertex has become a leading player in the pharmaceutical preparation manufacturing industry.
Vertex is renowned for its innovative approach to developing transformative medicines for serious diseases. Their core focus lies in discovering, developing, and commercialising small molecule drugs, particularly for genetically defined conditions.
Notably, Vertex holds a unique market position as a leader in cystic fibrosis (CF) treatment, having revolutionised care for many patients. Their commitment to scientific innovation continues to drive their pipeline, aiming to deliver life-changing therapies to underserved patient populations globally.
50
DitchCarbon score
+8 vs industry average
Vertex Pharmaceuticals’s score of 50 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Vertex Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Vertex Pharmaceuticals's reported carbon emissions
Vertex Pharmaceuticals, a US-based pharmaceutical preparation manufacturing company, reported its latest carbon emissions data for 2025. In 2025, the company's Scope 1 emissions were 12,296,000 kg CO2e, Scope 2 market-based emissions were 1,278,000 kg CO2e, and Scope 3 emissions totalled 579,649,000 kg CO2e. This data represents a disclosure across all three scopes.
Looking back, in 2024, Vertex Pharmaceuticals' Scope 1 emissions were 8,976,000 kg CO2e, Scope 2 market-based emissions were 3,930,000 kg CO2e, and Scope 3 emissions were 551,647,000 kg CO2e. For 2023, the company recorded Scope 1 emissions of 8,311,000 kg CO2e, Scope 2 market-based emissions of 4,888,000 kg CO2e, and Scope 3 emissions of 474,129,000 kg CO2e.
Vertex Pharmaceuticals has set a near-term absolute reduction target to decrease its Scope 1 and 2 greenhouse gas emissions by 42% by 2032, using 2022 as a baseline year. This commitment aligns with the Science Based Targets initiative (SBTi).
For historical context, in 2022, the company reported Scope 1 emissions of 2,000,000 kg CO2e and Scope 2 emissions of 3,000,000 kg CO2e. Prior to 2023, the company did not disclose Scope 3 emissions data. From 2014 to 2022, Vertex Pharmaceuticals consistently reported Scope 1 and 2 emissions, with Scope 1 remaining at 2,000,000 kg CO2e annually, and Scope 2 emissions fluctuating, ranging from 10,000,000 kg CO2e in 2014 down to 3,000,000 kg CO2e in 2021 and 2022.
Assessing Vertex Pharmaceuticals as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Vertex Pharmaceuticals and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Vertex Pharmaceuticals’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Vertex Pharmaceuticals5 months ago
50
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more